Stefanie Andrews

Stefanie Andrews has an extensive work experience in the pharmaceutical industry. Stefanie is currently the Director of Clinical Operations at Ventyx Biosciences since April 2022. Prior to their current role, they served as the Director of Clinical Operations at Intercept Pharmaceuticals from January 2021 to March 2022. Before that, they held the position of Associate Director of Clinical Operations at Intercept Pharmaceuticals from August 2018 to January 2021.

Stefanie's earlier work experience includes roles at The Medicines Company, Rempex Pharmaceuticals, Mpex Pharmaceuticals, Somaxon Pharmaceuticals, Cancervax Corporation, Maxim Pharmaceuticals, and Pfizer/Agouron Pharmaceuticals. Stefanie held various positions such as Senior Program Manager and Senior Clinical Project Manager at The Medicines Company, Clinical Project Manager and Senior Clinical Project Manager at Rempex Pharmaceuticals, Senior CRA and Clinical Project Manager at Mpex Pharmaceuticals, CRA II and Senior CRA at Somaxon Pharmaceuticals, and CRA at Cancervax Corporation. Stefanie also worked as a Document Specialist and CRA I at Maxim Pharmaceuticals and as a Safety Associate and Document Specialist at Pfizer/Agouron Pharmaceuticals.

Stefanie's work experience spans over two decades, showcasing their expertise and contributions in clinical operations and project management.

Stefanie Andrews received their Bachelor's degree in Psychology from UC Santa Barbara in the year 2000. During their time at UC Santa Barbara, they also completed a BA Minor in Exercise Health Sciences in the same year. In 2003, they obtained a Clinical Trials Administration Certification from UC San Diego Extension. In 2013, they obtained a Project Management Professional (PMP) Certification from the Project Management Institute.